Prescillia Lagarrigue

Dr. Prescillia Lagarrigue

CIRIMAT, Université de Toulouse, Toulouse, Occitanie, France
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Biomaterials
Verified
Journal Article
Closed access
JBJ. Barthes
J. Barthes
Prescillia LagarriguePrescillia Lagarrigue
Prescillia Lagarrigue
VRV. Riabov
V. Riabov
GLG. Lutzweiler
G. Lutzweiler
JKJ. Kirsch
J. Kirsch
ADAgnes Dupret-Bories
Agnes Dupret-Bories

22 December 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Prescillia LagarriguePrescillia Lagarrigue
Prescillia Lagarrigue
FMFilippo Moncalvo
Filippo Moncalvo
FCFRANCESCO CELLESI
FRANCESCO CELLESI
This review aims to highlight the importance of particle shape in the design of polymeric nanocarriers for drug delivery systems, along with their size, surface chemistry, density, and rigidity. Current manufacturing methods used to obtain non-spherical polymeric nanocarriers such as filomicelles or nanoworms, nanorods and nanodisks, are firstly described. Then, their interactions with biological barriers are presented, including how shape affects nanoparticle clearance, their biodistribution and targeting. Finally, their drug delivery properties and their therapeutic efficacy, both in vitro and in vivo, are discussed and compared with the characteristics of their spherical counterparts.

1 December 2020 in Polymer
Verified
Journal Article
Closed access
Prescillia LagarriguePrescillia Lagarrigue
Prescillia Lagarrigue
JSJérémy Soulié
Jérémy Soulié
DGDavid Grossin
David Grossin
ADAgnès Dupret-Bories
Agnès Dupret-Bories
CCChristèle Combes
Christèle Combes
VDVincent Darcos
Vincent Darcos

Verified
Journal Article
Open access
PDF file
IAIka Dewi Ana
Ika Dewi Ana
ALAny Lestari
Any Lestari
Prescillia LagarriguePrescillia Lagarrigue
Prescillia Lagarrigue
JSJérémy Soulié
Jérémy Soulié
ARAnggraeni Rahmi
Anggraeni Rahmi
Christophe DrouetChristophe Drouet
Christophe Drouet
Bone infections are a key health challenge with dramatic consequences for affected patients. In dentistry, periodontitis is a medically compromised condition for efficient dental care and bone grafting, the success of which depends on whether the surgical site is infected or not. Present treatments involve antibiotics associated with massive bacterial resistance effects, urging for the development of alternative antibacterial strategies. In this work, we established a safe-by-design bone substitute approach by combining bone-like apatite to peroxide ions close to natural in vivo oxygenated species aimed at fighting pathogens. In parallel, bone-like apatites doped with Ag+ or co-doped Ag+/peroxide were also prepared for comparative purposes. The compounds were thoroughly characterized by chemical titrations, FTIR, XRD, SEM, and EDX analyses. All doped apatites demonstrated significant antibacterial properties toward four major pathogenic bacteria involved in periodontitis and bone infection, namely Porphyromonas gingivalis (P. gingivalis), Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), Fusobacterium nucleatum (F. nucleatum), and S. aureus. By way of complementary tests to assess protein adsorption, osteoblast cell adhesion, viability and IC50 values, the samples were also shown to be highly biocompatible. In particular, peroxidated apatite was the safest material tested, with the lowest IC50 value toward osteoblast cells. We then demonstrated the possibility to associate such doped apatites with two biocompatible polymers, namely gelatin and poly(lactic-co-glycolic) acid PLGA, to prepare, respectively, composite 2D membranes and 3D scaffolds. The spatial distribution of the apatite particles and polymers was scrutinized by SEM and µCT analyses, and their relevance to the field of bone regeneration was underlined. Such bio-inspired antibacterial apatite compounds, whether pure or associated with (bio)polymers are thus promising candidates in dentistry and orthopedics while providing an alternative to antibiotherapy.

7 April 2022 in ACS Applied Nano Materials
Verified
Journal Article
Closed access
Prescillia LagarriguePrescillia Lagarrigue
Prescillia Lagarrigue
VDVincent Darcos
Vincent Darcos
CTChristophe Tenailleau
Christophe Tenailleau
BDBenjamin Duployer
Benjamin Duployer
ADAgnès Dupret-Bories
Agnès Dupret-Bories
JSJérémy Soulié
Jérémy Soulié

19 June 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
HKHyoung-Jun Kim
Hyoung-Jun Kim
Prescillia LagarriguePrescillia Lagarrigue
Prescillia Lagarrigue
JOJae-Min Oh
Jae-Min Oh
JSJérémy Soulié
Jérémy Soulié
FSFabrice Salles
Fabrice Salles
Christophe DrouetChristophe Drouet
Christophe Drouet
Layered Double Hydroxides (LDHs) are inorganic compounds of relevance to various domains, where their surface reactivity and/or intercalation capacities can be advantageously exploited for the retention/release of ionic and molecular species. In this study, we have explored specifically the applicability in the field of bone regeneration of one LDH composition, denoted “MgFeCO3”, of which components are already present in vivo, so as to convey a biocompatibility character. The propensity to be used as a bone substitute depends, however, on their ability to allow the fabrication of 3D constructs able to be implanted in bone sites. In this work, we display two appealing approaches for the processing of MgFeCO3 LDH particles to prepare (i) porous 3D scaffolds by freeze-casting, involving an alginate biopolymeric matrix, and (ii) pure MgFeCO3 LDH monoliths by Spark Plasma Sintering (SPS) at low temperature. We then explored the capacity of such LDH particles or monoliths to interact quantitatively with molecular moieties/drugs in view of their local release. The experimental data were complemented by computational chemistry calculations (Monte Carlo) to examine in more detail the mineral–organic interactions at play. Finally, preliminary in vitro tests on osteoblastic MG63 cells confirmed the high biocompatible character of this LDH composition. It was confirmed that (i) thermodynamically metastable LDH could be successfully consolidated into a monolith through SPS, (ii) the LDH particles could be incorporated into a polymer matrix through freeze casting, and (iii) the LDH in the consolidated monolith could incorporate and release drug molecules in a controlled manner. In other words, our results indicate that the MgFeCO3 LDH (pyroaurite structure) may be seen as a new promising compound for the setup of bone substitute biomaterials with tailorable drug delivery capacity, including for personalized medicine.